10:14 EDT Insmed (INSM) trading halted, news pending
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSM:
- Insmed’s Earnings Call Highlights Strong Portfolio and Growth
- Insmed price target raised to $120 from $108 at RBC Capital
- Insmed price target raised to $133 from $124 at UBS
- Insmed Positioned for Growth: Buy Rating Backed by Brensocatib Launch and Strong Pipeline
- Insmed Reports Strong Growth and Strategic Advances